HealthRx.com

What Dana White's TRT Protocol Would Cost Outside a Celebrity Context

By
Published Updated Last reviewed
Prescription access and medication affordability image for What Dana White's TRT Protocol Would Cost Outside a Celebrity Context
Clinical image for What Dana White's TRT Protocol Would Cost Outside a Celebrity Context Image: HealthRX.com clinical image

What Dana White Has Actually Said About TRT

Dana White, the president of the UFC, has spoken publicly about his use of testosterone replacement therapy in interviews and on social media. In a 2023 appearance on the Full Send Podcast, White discussed his health optimization regimen, which he described as including TRT alongside other interventions. He has also referenced rapid body composition changes tied to working with performance-medicine physicians.

What White has not publicly confirmed: specific testosterone formulations, dosing schedules, whether he uses human chorionic gonadotropin (hCG) or an aromatase inhibitor alongside testosterone, or the clinical indication (low testosterone diagnosis vs. optimization). The specifics of his protocol remain speculated. Publicly available details stop at the general admission that testosterone is part of his regimen.

This matters because the UFC's own history with TRT therapeutic use exemptions (TUEs), which the organization banned in 2014, makes White's public posture on testosterone a signal that shapes how millions of combat-sport fans think about the therapy.

What TRT Actually Costs: The Full Picture

For a man who walks into a clinic with symptoms of low testosterone (fatigue, decreased libido, loss of muscle mass, mood changes) and receives a confirmed diagnosis via two morning serum testosterone draws below 300 ng/dL, here is what the financial commitment looks like in 2026.

The Testosterone Itself

Testosterone cypionate, the most commonly prescribed injectable formulation in the United States, is the baseline. A 10 mL vial of 200 mg/mL testosterone cypionate (the standard concentration) typically lasts 10 to 20 weeks depending on dose.

With commercial insurance (generic): $10 to $40 per vial at a retail pharmacy with a copay. Many insurers cover testosterone cypionate on formulary tier 1 or 2 when the diagnosis code (ICD-10 E29.1, testicular hypofunction) is documented and labs confirm deficiency.

Without insurance (cash pay): $30 to $90 per vial at major retail chains. GoodRx-type discount cards frequently bring the price below $50.

Branded or compounded options: Testosterone undecanoate (Aveed), an injectable given every 10 weeks in-office, carries a list price above $3,000 per injection. Oral testosterone undecanoate (Jatenzo) runs approximately $600 to $900 per month without insurance. Compounded testosterone creams from 503A pharmacies cost $50 to $150 per month. These premium options are where costs diverge sharply from the generic injectable baseline.

The HealthRX.com Medical Team notes that for a patient on standard testosterone cypionate at 100 to 200 mg per week (a dose range consistent with Endocrine Society Clinical Practice Guidelines), the testosterone itself is rarely the expensive part.

Lab Work

Before prescribing TRT, a responsible clinician orders baseline labs: total testosterone, free testosterone, sex hormone-binding globulin (SHBG), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estradiol, complete blood count (CBC), comprehensive metabolic panel (CMP), lipid panel, and prostate-specific antigen (PSA) in men over 40. This panel runs $200 to $500 out of pocket or is covered (minus copay) under most insurance plans when ordered with a diagnostic code.

Follow-up labs are drawn at 6 to 12 weeks after initiation, then every 6 to 12 months. Each follow-up panel costs $100 to $300 without insurance. Over a year, a patient should expect two to three lab draws, totaling $200 to $900 if paying cash. The American Urological Association recommends monitoring hematocrit on every CBC because testosterone stimulates erythropoiesis, and a hematocrit above 54% is a signal to reduce dose or perform a therapeutic phlebotomy.

Provider Visits

Traditional endocrinologist or urologist: Office visits run $150 to $350 per visit without insurance. Most patients see their prescribing physician two to four times per year.

Men's health or TRT telehealth clinics: Monthly subscription models ($99 to $249 per month) have proliferated since 2020. These typically bundle provider access, lab orders, and sometimes the medication itself. The convenience is real. The tradeoff: some of these clinics prescribe testosterone with minimal diagnostic rigor, which the Endocrine Society has explicitly cautioned against.

Concierge or performance medicine (the "Dana White tier"): The physicians publicly associated with celebrity health optimization charge $1,000 to $5,000 per month in retainer fees. These practices include frequent labs, body-composition scans, and access to a broader pharmacopeia (peptides, growth hormone secretagogues, NAD+ infusions). This tier of care is not medically necessary for TRT, but it is the context in which public figures like White typically access testosterone.

Ancillary Medications

A responsible TRT protocol often involves more than testosterone alone.

Aromatase inhibitor (anastrozole): Prescribed when estradiol levels rise above target range (a side effect of testosterone aromatizing to estrogen). Generic anastrozole costs $5 to $25 per month. Not every patient needs one, and routine co-prescription without lab confirmation of elevated estradiol is considered poor practice.

Human chorionic gonadotropin (hCG): Used to maintain testicular volume and preserve fertility while on exogenous testosterone. Since an FDA enforcement action in 2020 removed hCG from compounding pharmacies (it is now available only as the branded product Pregnyl or biosimilar), costs have risen to $100 to $300 per month. Patients who want fertility preservation should discuss this cost with their provider before starting TRT, because exogenous testosterone suppresses spermatogenesis, sometimes irreversibly in a subset of men.

Insurance: The Real Gatekeeper

Whether insurance covers TRT depends on three variables: the diagnosis, the formulation, and the insurer.

What insurers typically cover: Generic testosterone cypionate injections with a documented diagnosis of hypogonadism and confirmatory labs. Most commercial plans and many Medicare Part D formularies include this.

What insurers resist or deny: Topical gels (AndroGel, Testim) are often subject to prior authorization or step therapy requiring a trial of injectables first. Brand injectables like Aveed frequently require specialty pharmacy authorization. Compounded formulations are almost never covered. "Optimization" without a formal hypogonadism diagnosis is categorically excluded.

The prior authorization bottleneck: Even for covered formulations, prior authorization delays TRT initiation by an average of 7 to 14 days. The HealthRX.com Medical Team recommends patients ask their prescriber to submit prior authorization paperwork at the same visit the labs are reviewed, not after a denied pharmacy claim.

The Annual Cost Breakdown for a Non-Celebrity Patient

At a glance

  • Testosterone cypionate (insured): $120 to $480 per year
  • Testosterone cypionate (cash): $150 to $540 per year
  • Lab work (insured, with copays): $60 to $200 per year
  • Lab work (cash): $200 to $900 per year
  • Provider visits (insured): $100 to $300 per year (copays)
  • Provider visits (cash): $300 to $1,400 per year
  • Ancillary meds (if needed): $60 to $3,600 per year (wide range based on hCG use)
  • Total insured range: roughly $340 to $1,200 per year
  • Total cash-pay range: roughly $700 to $6,400 per year
  • Concierge "celebrity-tier" range: $12,000 to $60,000-plus per year

The gap between the insured baseline and the concierge tier is not driven by better testosterone. It is driven by access: faster labs, more frequent monitoring, personalized dosing adjustments, and a broader menu of adjunctive therapies whose evidence base ranges from solid (hCG for fertility) to speculative (peptide stacks with limited Phase III trial data).

The HealthRX.com Medical Team Take

Dana White's public discussion of TRT has done something useful: it has moved testosterone therapy out of the shadows for a demographic (men 40 to 65) that historically avoids the doctor. The risk is that his experience, shaped by unlimited resources and concierge medical access, creates unrealistic expectations for the average patient.

A man with clinically confirmed low testosterone can access safe, effective, guideline-concordant TRT for under $100 per month with insurance, and under $200 per month without it, if he sticks to generic testosterone cypionate, finds a competent prescriber, and gets his labs done on schedule. The expensive additions (compounded creams, branded long-acting injectables, hCG, concierge retainers) are choices, not requirements.

The most important cost is not financial. It is the cost of not monitoring. Testosterone raises hematocrit, can suppress HDL cholesterol, and carries cardiovascular risk signals that the TRAVERSE trial helped clarify in 2023. Skipping follow-up labs to save $150 is a false economy. The celebrity protocol and the budget protocol should have one thing in common: consistent, evidence-based monitoring by a physician who treats lab values, not marketing copy.

Frequently asked questions

›
›
›
›
›

References

Take Our Free 2-min Assessment
Start now